6 days Ago By Defense World Staff
Cryoport (NASDAQ:CYRX – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at Needham & Company LLC in a report released on Thursday,Benzinga reports. They currently have a $11.00 price target on the stock.
Needham & Company LLC’s price objective points to a potential upside of 90.64% from the stock’s previous close.Other analysts have also recently issued research reports about the company.
Roth Mkm reaffirmed a “buy” rating and issued a $15.00 price target on shares of Cryoport in a research report on Tuesday, April 1st. UBS Group raised their price target on shares of Cryoport from $10.
00 to $11.00 and gave the stock a “buy” rating in a research report on Tuesday, April 1st. Finally, Guggenheim started coverage on Cryoport in a research report on Thursday, December 19th.
They set a “buy” rating and a $11.00 price objective on the stock. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company.
According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $11.83.
View Our Latest Analysis on CYRXCryoport Trading Up 10.3 %Shares of NASDAQ:CYRX opened at $5.77 on Thursday.
The company has a debt-to-equity ratio of 0.48, a quick ratio of 5.32 and a current ratio of 5.
70. Cryoport has a 1-year low of $4.58 and a 1-year high of $17.
95. The stock has a market capitalization of $287.98 million, a price-to-earnings ratio of -1.
71 and a beta of 1.81. The company has a 50 day moving average price of $6.
12 and a 200 day moving average price of $7.10. Cryoport (NASDAQ:CYRX – Get Free Report) last announced its quarterly earnings data on Tuesday, March 4th.
The company reported ($0.42) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.
09). Cryoport had a negative net margin of 70.08% and a negative return on equity of 13.
35%. The company had revenue of $59.53 million for the quarter, compared to analysts’ expectations of $58.
71 million. During the same period in the previous year, the firm posted ($0.29) earnings per share.
On average, research analysts anticipate that Cryoport will post -0.99 EPS for the current fiscal year. Insider Activity at CryoportIn other news, CEO Jerrell Shelton sold 4,620 shares of Cryoport stock in a transaction on Monday, March 17th.
The stock was sold at an average price of $6.29, for a total value of $29,059.80.
Following the completion of the sale, the chief executive officer now directly owns 765,399 shares of the company’s stock, valued at approximately $4,814,359.71. This trade represents a 0.
60 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold 19,830 shares of company stock valued at $118,353 in the last ninety days.
Insiders own 10.10% of the company’s stock. Institutional Trading of CryoportSeveral institutional investors and hedge funds have recently made changes to their positions in the business.
Cadian Capital Management LP increased its holdings in shares of Cryoport by 14.1% in the fourth quarter. Cadian Capital Management LP now owns 4,927,027 shares of the company’s stock worth $38,332,000 after acquiring an additional 609,021 shares in the last quarter.
Millennium Management LLC increased its position in Cryoport by 11.0% during the fourth quarter. Millennium Management LLC now owns 4,139,869 shares of the company’s stock worth $32,208,000 after buying an additional 409,353 shares during the last quarter.
Deutsche Bank AG grew its stake in Cryoport by 0.9% in the 4th quarter. Deutsche Bank AG now owns 1,397,121 shares of the company’s stock valued at $10,870,000 after buying an additional 12,864 shares during the last quarter.
Geode Capital Management LLC lifted its holdings in shares of Cryoport by 3.6% during the third quarter. Geode Capital Management LLC now owns 1,097,369 shares of the company’s stock worth $8,902,000 after buying an additional 38,520 shares in the last quarter.
Finally, State Street Corp increased its holdings in shares of Cryoport by 2.8% during the third quarter. State Street Corp now owns 1,003,080 shares of the company’s stock worth $8,135,000 after purchasing an additional 27,438 shares during the period.
Institutional investors own 92.90% of the company’s stock. About Cryoport (Get Free Report)Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.Further ReadingFive stocks we like better than CryoportHow to Use the MarketBeat Dividend CalculatorJPMorgan is a Buy, if You Can Handle The Volatility Golden Cross Stocks: Pattern, Examples and Charts United States Steel’s Crash: An Unmissable Buying OpportunityWhat is the Hang Seng index? Rocket Lab Stock: Weathering the Storm, Time for a Comeback?.
